Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
Publication
, Journal Article
St Clair, EW
Published in: Arthritis Rheum
March 2012
Duke Scholars
Published In
Arthritis Rheum
DOI
EISSN
1529-0131
Publication Date
March 2012
Volume
64
Issue
3
Start / End Page
604 / 608
Location
United States
Related Subject Headings
- Rituximab
- Male
- Immunologic Factors
- Humans
- Hepatitis C, Chronic
- Female
- Drug Resistance, Viral
- Cryoglobulinemia
- Arthritis & Rheumatology
- Antiviral Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
St Clair, E. W. (2012). Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. Arthritis Rheum, 64(3), 604–608. https://doi.org/10.1002/art.34326
St Clair, E William. “Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.” Arthritis Rheum 64, no. 3 (March 2012): 604–8. https://doi.org/10.1002/art.34326.
St Clair EW. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. Arthritis Rheum. 2012 Mar;64(3):604–8.
St Clair, E. William. “Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.” Arthritis Rheum, vol. 64, no. 3, Mar. 2012, pp. 604–08. Pubmed, doi:10.1002/art.34326.
St Clair EW. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. Arthritis Rheum. 2012 Mar;64(3):604–608.
Published In
Arthritis Rheum
DOI
EISSN
1529-0131
Publication Date
March 2012
Volume
64
Issue
3
Start / End Page
604 / 608
Location
United States
Related Subject Headings
- Rituximab
- Male
- Immunologic Factors
- Humans
- Hepatitis C, Chronic
- Female
- Drug Resistance, Viral
- Cryoglobulinemia
- Arthritis & Rheumatology
- Antiviral Agents